Distinct from the naïve condition, cells from the tumor-bearing animal migrate to CCL2 with a slightly higher potency as compared to CCL7 and achieve near-maximum migration to both ligands at as low as 3ng/mL of recombinant protein plated in the bottom chamber. The gene discussed is CCL2; the disease is neoplasm.